{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:12:29Z","timestamp":1792465949435,"version":"4.5.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Backgrounds<\/jats:title>\n                    <jats:p>The incidence of acute kidney injury and the association between acute kidney injury and prognosis have been reported about transcatheter arterial chemoembolization using anthracycline. However, the incidence of acute kidney injury after platinum-based transarterial chemoembolization or transarterial infusion chemotherapy remains unclear. The aim of this study was to investigate association between acute kidney injury after platinum-based transcatheter arterial chemoembolization\/transarterial infusion chemotherapy and prognosis in patients with hepatocellular carcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analysed 270 sessions in 129 patients who underwent platinum-based transcatheter arterial chemoembolization\/transarterial infusion chemotherapy. Acute kidney injury was diagnosed according to the criteria established by the International Club of Ascites. The incidence of acute kidney injury, risk factors for serum creatinine elevation and association between acute kidney injury and prognosis were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifteen cases of acute kidney injury (5.6%, 15\/270) developed in 14 patients (10.8%, 14\/129). Ascites (coefficient: 0.059, P\u00a0=\u00a00.006), low estimated glomerular filtration rate (coefficient: \u22120.008, P\u00a0=\u00a00.029), diabetes (coefficient: 0.072, P\u00a0&amp;lt;\u00a00.001) and high albumin\u2013bilirubin grade (albumin\u2013bilirubin grade 2: coefficient: 0.053, P\u00a0=\u00a00.004; and albumin\u2013bilirubin grade 3: coefficient: 0.103, P\u00a0&amp;lt;\u00a00.001) were significantly associated with an elevation in serum creatinine levels after transcatheter arterial chemoembolization\/transarterial infusion chemotherapy. The development of acute kidney injury was associated with poor prognosis (hazard ratio: 3.18, 95%CI: 1.411\u20137.171, P\u00a0=\u00a00.005). Patients with acute kidney injury had a significantly lower survival rate than patients without acute kidney injury (log-rank test; P\u00a0=\u00a00.034).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The incidence of acute kidney injury after platinum-based transcatheter arterial chemoembolization\/transarterial infusion chemotherapy was consistent with that after transcatheter arterial chemoembolization using anthracycline, and the development of acute kidney injury was associated with poor prognosis. Ascites, diabetes, low estimated glomerular filtration rate and high albumin\u2013bilirubin grade were risk factors for serum creatinine elevation after platinum-based transcatheter arterial chemoembolization\/transarterial infusion chemotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jjco\/hyz129","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T08:12:22Z","timestamp":1564733542000},"page":"36-43","source":"Crossref","is-referenced-by-count":10,"title":["Acute kidney injury after platinum-based transcatheter arterial chemoembolization and transarterial infusion chemotherapy in patients with hepatocellular carcinoma"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2213-3918","authenticated-orcid":false,"given":"Manabu","family":"Hayashi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumichi","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Okai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Ohira","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,28]]},"reference":[{"key":"2020012404164050000_ref1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"2020012404164050000_ref2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"2020012404164050000_ref3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ajg.2011.425","article-title":"Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors","volume":"107","author":"Shiina","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"2020012404164050000_ref4","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000003192","article-title":"Liver resection for multiple hepatocellular carcinomas: A Japanese nationwide survey","author":"Fukami","year":"2019","journal-title":"Ann Surg"},{"key":"2020012404164050000_ref5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/hepr.13259","article-title":"Recent advances in medical management of hepatocellular carcinoma","volume":"49","author":"Ikeda","year":"2019","journal-title":"Hepatol Res"},{"key":"2020012404164050000_ref6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"2020012404164050000_ref7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: Management of hepatocellular carcinoma","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"key":"2020012404164050000_ref8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: A 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"key":"2020012404164050000_ref9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00535-017-1374-6","article-title":"Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: A phase III randomized trial","volume":"53","author":"Ikeda","year":"2018","journal-title":"J Gastroenterol"},{"key":"2020012404164050000_ref10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/gutjnl-2016-312670","article-title":"Acute-on-chronic liver failure: An update","volume":"66","author":"Hernaez","year":"2017","journal-title":"Gut"},{"key":"2020012404164050000_ref11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/hepr.13064","article-title":"A multicenter pilot survey to clarify the clinical features of patients with acute-on-chronic liver failure in Japan","volume":"48","author":"Nakayama","year":"2018","journal-title":"Hepatol Res"},{"key":"2020012404164050000_ref12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gutjnl-2011-301255","article-title":"Acute kidney injury in decompensated cirrhosis","volume":"62","author":"Tsien","year":"2013","journal-title":"Gut"},{"key":"2020012404164050000_ref13","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.08.051","article-title":"New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection","volume":"145","author":"Wong","year":"2013","journal-title":"Gastroenterology"},{"key":"2020012404164050000_ref14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.25735","article-title":"Association of AKI with mortality and complications in hospitalized patients with cirrhosis","volume":"57","author":"Belcher","year":"2013","journal-title":"Hepatology"},{"key":"2020012404164050000_ref15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"key":"2020012404164050000_ref16","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/hep.30058","article-title":"\u201cNormal\u201d creatinine levels predict persistent kidney injury and waitlist mortality in outpatients with cirrhosis","volume":"68","author":"Cullaro","year":"2018","journal-title":"Hepatology"},{"key":"2020012404164050000_ref17","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ajg.2017.122","article-title":"Acute kidney injury in cirrhosis: Baseline serum creatinine predicts patient outcomes","volume":"112","author":"Wong","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"2020012404164050000_ref18","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1007\/s00330-017-4893-x","article-title":"Risk of acute kidney injury after transarterial chemoembolisation in hepatocellular carcinoma patients: A nationwide population-based cohort study","volume":"27","author":"Lee","year":"2017","journal-title":"Eur Radiol"},{"key":"2020012404164050000_ref19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa021833","article-title":"Nephrotoxic effects in high-risk patients undergoing angiography","volume":"348","author":"Aspelin","year":"2003","journal-title":"N Engl J Med"},{"key":"2020012404164050000_ref20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1478-3231.2004.00911.x","article-title":"Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: A prospective study","volume":"24","author":"Huo","year":"2004","journal-title":"Liver Int"},{"key":"2020012404164050000_ref21","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00330-014-3099-8","article-title":"The incidence of contrast-induced nephropathy (CIN) following transarterial chemoembolisation (TACE) in patients with hepatocellular carcinoma (HCC)","volume":"24","author":"Hayakawa","year":"2014","journal-title":"Eur Radiol"},{"key":"2020012404164050000_ref22","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1365-2036.2004.01936.x","article-title":"Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: A retrospective study of the incidence, risk factors, clinical course and long-term outcome","volume":"19","author":"Huo","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"2020012404164050000_ref23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijsu.2018.03.049","article-title":"TransArterial ChemoEmbolization (TACE) with platinum versus anthracyclines for hepatocellular carcinoma: A meta-analysis","volume":"53","author":"Zhao","year":"2018","journal-title":"Int J Surg"},{"key":"2020012404164050000_ref24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10120-017-0753-2","article-title":"A phase II study of combination therapy with oral S-1 and cisplatin in elderly patients with advanced gastric cancer","volume":"21","author":"Sasaki","year":"2018","journal-title":"Gastric Cancer"},{"key":"2020012404164050000_ref25","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/sj.bjc.6600884","article-title":"Weekly high-dose cisplatin is a feasible treatment option: Analysis on prognostic factors for toxicity in 400 patients","volume":"88","author":"de Jongh","year":"2003","journal-title":"Br J Cancer"},{"key":"2020012404164050000_ref26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"2020012404164050000_ref27","first-page":"810","article-title":"Variceal hemorrhage, hepatic cirrhosis, and portacaval shunts","volume":"73","author":"Turcotte","year":"1973","journal-title":"Surgery"},{"key":"2020012404164050000_ref28","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis","volume":"375","author":"Chronic Kidney Disease Prognosis Consortium","year":"2010","journal-title":"Lancet"},{"key":"2020012404164050000_ref29","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1080\/00365521.2018.1548645","article-title":"Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma","volume":"53","author":"Endo","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"2020012404164050000_ref30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S1499-3872(16)60089-9","article-title":"Combined hepatectomy and radiofrequency ablation versus TACE in improving survival of patients with unresectable BCLC stage B HCC","volume":"15","author":"Hou","year":"2016","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"2020012404164050000_ref31","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"2020012404164050000_ref32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1159\/000157322","article-title":"Acute kidney injury after transarterial chemoembolization for hepatocellular carcinoma: A retrospective analysis","volume":"26","author":"Park","year":"2008","journal-title":"Blood Purif"},{"key":"2020012404164050000_ref33","doi-asserted-by":"crossref","first-page":"e0180408","DOI":"10.1371\/journal.pone.0180408","article-title":"Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization","volume":"12","author":"Ho","year":"2017","journal-title":"PLoS One"},{"key":"2020012404164050000_ref34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s001340050780","article-title":"Renal failure in liver disease","volume":"25","author":"Eckardt","year":"1999","journal-title":"Intensive Care Med"},{"key":"2020012404164050000_ref35","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3748\/wjg.15.1459","article-title":"Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis","volume":"15","author":"Lodhia","year":"2009","journal-title":"World J Gastroenterol"},{"key":"2020012404164050000_ref36","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.1016\/j.ejrad.2013.04.029","article-title":"Contrast induced nephropathy in patients undergoing intravenous (IV) contrast enhanced computed tomography (CECT) and the relationship with risk factors: A meta-analysis","volume":"82","author":"Moos","year":"2013","journal-title":"Eur J Radiol"},{"key":"2020012404164050000_ref37","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","article-title":"Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma","volume":"126","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"key":"2020012404164050000_ref38","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/nep.12649","article-title":"The impact of acute kidney injury in diabetes mellitus","volume":"21","author":"Johnson","year":"2016","journal-title":"Nephrology (Carlton)"},{"key":"2020012404164050000_ref39","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jacc.2007.12.035","article-title":"Contrast-induced acute kidney injury","volume":"51","author":"McCullough","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2020012404164050000_ref40","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0002-9343(97)00150-2","article-title":"Acute renal failure after coronary intervention, incidence, risk factors, and relationship to mortality","volume":"103","author":"McCullough","year":"1997","journal-title":"Am J Med"},{"key":"2020012404164050000_ref41","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/hepr.12376","article-title":"Efficacy and safety of cisplatin versus miriplatin in transcatheter arterial chemoembolization and transarterial infusion chemotherapy for hepatocellular carcinoma: A randomized controlled trial","volume":"45","author":"Otsuji","year":"2015","journal-title":"Hepatol Res"},{"key":"2020012404164050000_ref42","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/hepr.12212","article-title":"Comparison of the antitumor efficacy of transcatheter arterial chemoembolization with a miriplatin-iodized oil suspension and a cisplatin-iodized oil suspension for hepatocellular carcinoma","volume":"43","author":"Ueda","year":"2013","journal-title":"Hepatol Res"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/50\/1\/36\/31952737\/hyz129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/50\/1\/36\/31952737\/hyz129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T12:45:49Z","timestamp":1721565949000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/50\/1\/36\/5607888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,28]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,10,28]]},"published-print":{"date-parts":[[2020,1,24]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyz129","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,1]]},"published":{"date-parts":[[2019,10,28]]}}}